Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 43% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 84% | 237.97 | 549 / 653 | 50% | 1.15 | 301 / 605 |
| breast | 80% | 526.31 | 369 / 459 | 45% | 1.03 | 499 / 1118 |
| prostate | 73% | 212.04 | 178 / 245 | 48% | 0.88 | 243 / 502 |
| muscle | 100% | 5156.66 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 8316.75 | 839 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 78% | 221.38 | 201 / 258 | 19% | 0.70 | 43 / 230 |
| adipose | 87% | 737.93 | 1052 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 38% | 69.38 | 8 / 21 | 39% | 0.82 | 199 / 504 |
| skin | 65% | 205.29 | 1171 / 1809 | 4% | 0.09 | 18 / 472 |
| esophagus | 6% | 13.06 | 87 / 1445 | 44% | 0.79 | 80 / 183 |
| intestine | 13% | 27.76 | 123 / 966 | 35% | 0.57 | 182 / 527 |
| lung | 11% | 29.42 | 63 / 578 | 32% | 0.73 | 375 / 1155 |
| kidney | 8% | 11.76 | 7 / 89 | 32% | 0.60 | 289 / 901 |
| stomach | 9% | 17.22 | 32 / 359 | 30% | 0.57 | 87 / 286 |
| ovary | 5% | 10.03 | 9 / 180 | 29% | 0.64 | 126 / 430 |
| uterus | 7% | 25.79 | 12 / 170 | 25% | 1.26 | 115 / 459 |
| liver | 11% | 16.93 | 24 / 226 | 14% | 0.22 | 58 / 406 |
| pancreas | 9% | 15.97 | 29 / 328 | 11% | 0.19 | 19 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 18% | 0.41 | 8 / 45 |
| brain | 6% | 10.62 | 158 / 2642 | 3% | 0.05 | 24 / 705 |
| blood vessel | 8% | 64.47 | 111 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
| spleen | 1% | 1.80 | 3 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.76 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001933 | Biological process | negative regulation of protein phosphorylation |
| GO_0046329 | Biological process | negative regulation of JNK cascade |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| Gene name | KLHL31 |
| Protein name | Kelch-like protein 31 (BTB and kelch domain-containing protein 6) (Kelch repeat and BTB domain-containing protein 1) (Kelch-like protein KLHL) |
| Synonyms | KBTBD1 BKLHD6 KLHL |
| Description | FUNCTION: Transcriptional repressor in MAPK/JNK signaling pathway to regulate cellular functions. Overexpression inhibits the transcriptional activities of both the TPA-response element (TRE) and serum response element (SRE). . |
| Accessions | Q9H511 ENST00000407079.1 ENST00000370905.4 |